MicroRNA in pancreatic cancer (Q38850617)

7 September 2017

1 reference

title

MicroRNA in pancreatic cancer (English)

1 reference

7 September 2017

1 reference

1 reference

Keiichi Yonemori

1 reference

7 September 2017

Hiroshi Kurahara

series ordinal

1 reference

7 September 2017

Kosei Maemura

series ordinal

1 reference

7 September 2017

Shoji Natsugoe

series ordinal

1 reference

7 September 2017

publication date

2 June 2016

1 reference

Journal of Human Genetics

7 September 2017

published in

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

33-40

1 reference

MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Circulating microRNAs as biomarkers for inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA in cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Advances in identification and validation of plant microRNAs and their target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Mirna expression profiles identify drivers in colorectal and pancreatic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miR-216a may inhibit pancreatic tumor growth by targeting JAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Impacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Pancreatic Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Oncogenic KRAS signalling in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Emerging role of the KRAS-PDK1 axis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Endogenous viruses: insights into viral evolution and impact on host biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The JAK/STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Transforming growth factor-β and the hallmarks of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Regulating Fbw7 on the road to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Ubiquitin-mediated control of oncogene and tumor suppressor gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-222 Controls Human Pancreatic Cancer Cell Line Capan-2 Proliferation by P57 Targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

CDC25 phosphatases in cancer cells: key players? Good targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Targeting apoptosis pathways in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Apoptosis pathways and their therapeutic exploitation in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Bcl-2 Upregulation Induced by miR-21 Via a Direct Interaction Is Associated with Apoptosis and Chemoresistance in MIA PaCa-2 Pancreatic Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Up-regulated expression of miR-23a/b targeted the pro-apoptotic Fas in radiation-induced thymic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

APAF-1 signaling in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Oncogenic miR-23a in Pancreatic Ductal Adenocarcinogenesis Via Inhibiting APAF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Blinded by the Light: The Growing Complexity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Regulation of p53 by ING family members in suppression of tumor initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Dysregulation of miR-15a and miR-214 in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Regulation of Bim in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The role of FoxO in the regulation of metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Regulation of mammalian DNA methyltransferases: a route to new mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The emerging roles of YAP and TAZ in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MiR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2016.59

MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway

21 January 2018

1 reference

12 December 2020

The functions and regulation of the PTEN tumour suppressor

1 reference

12 December 2020

ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer

1 reference

12 December 2020

MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy

1 reference

12 December 2020

MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma

1 reference

12 December 2020

Pancreatic Cancer Registry in Japan: 20 years of experience

1 reference

12 December 2020

Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis

1 reference

12 December 2020

miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer

1 reference

12 December 2020

hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration

1 reference

12 December 2020

MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1

1 reference

12 December 2020

MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.

1 reference

12 December 2020

Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.

1 reference

12 December 2020

Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1.

1 reference

12 December 2020

Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway

1 reference

12 December 2020

DNA methyl transferase 1: regulatory mechanisms and implications in health and disease.

1 reference

12 December 2020

The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma

1 reference

12 December 2020

The emerging and diverse roles of sirtuins in cancer: a clinical perspective

1 reference

12 December 2020

MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma

1 reference

12 December 2020

TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity

1 reference

12 December 2020

miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2.

1 reference

12 December 2020

Identifiers

DOI

10.1038/JHG.2016.59

1 reference

7 September 2017

1 reference